Plain-English translation of NCT05584124 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Stroke research guide →Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This study is testing repetitive transcranial magnetic stimulation (rTMS)—a non-invasive brain stimulation technique—as a possible treatment for the severe, ongoing fatigue that many people experience after a stroke. rTMS uses magnetic pulses applied to your scalp to stimulate brain activity in areas affected by stroke. Researchers want to see if this treatment can help reduce fatigue and improve daily functioning in stroke survivors.
Post-stroke fatigue is a common and debilitating symptom that often doesn't improve with standard treatments, leaving many stroke survivors struggling with everyday activities. This trial exists to explore whether this non-invasive brain stimulation approach might offer a new option for people whose fatigue hasn't responded to other treatments.
You likely qualify if…
You likely don't qualify if…
If you enroll, you will be randomly assigned to receive either real brain stimulation or sham (placebo) stimulation. During each session, magnetic pulses will be applied to your scalp for about 40 minutes. You will not know which group you're in, which helps researchers fairly measure whether the treatment actually works. The study involves multiple visits to the Atlanta VA Medical Center, and the research team will monitor your fatigue levels and other symptoms throughout the trial.
AI-generated summary from trial data · Jun 10, 2026 · Not medical advice
United States